Report Detail
Global and China Antiparasitic Drugs Market Size, Status and Forecast 2020-2026
- RnM4068942 |
- 19 June, 2020 |
- Global |
- 125 Pages |
- QYResearch |
- Pharma & Healthcare
Global Antiparasitic Drugs Scope and Market Size
Antiparasitic Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Antiparasitic Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Market segment by Type, the product can be split into
by Type
Anthelmintics
Antiprotozoals
Others
by Delivery Type
Oral
Injectable
Topical
Market segment by Application, split into
Hospital
Clinic
Others
Based on regional and country-level analysis, the Antiparasitic Drugs market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
In the competitive analysis section of the report, leading as well as prominent players of the global Antiparasitic Drugs market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The key players covered in this study
Ipca Laboratories Ltd
Zydus Cadila
Merck
Pfizer
GlaxoSmithKline Plc.
Cipla Ltd
Ranbaxy Laboratories
Novartis AG
Alvizia Health Care
Bayer AG
Roche Inc
Arbor Pharmaceuticals Inc.
Sanofi
AstraZeneca
Alkem Laboratories Limited
1 Report Overview
- 1.1 Study Scope
- 1.2 Market Analysis by Type
- 1.2.1 Global Antiparasitic Drugs Market Size Growth Rate by Type: 2020 VS 2026
- 1.2.2 Anthelmintics
- 1.2.3 Antiprotozoals
- 1.2.4 Others
- 1.3 Market by Application
- 1.3.1 Global Antiparasitic Drugs Market Share by Application: 2020 VS 2026
- 1.3.2 Hospital
- 1.3.3 Clinic
- 1.3.4 Others
- 1.4 Study Objectives
- 1.5 Years Considered
2 Global Growth Trends
- 2.1 Global Antiparasitic Drugs Market Perspective (2015-2026)
- 2.2 Global Antiparasitic Drugs Growth Trends by Regions
- 2.2.1 Antiparasitic Drugs Market Size by Regions: 2015 VS 2020 VS 2026
- 2.2.2 Antiparasitic Drugs Historic Market Share by Regions (2015-2020)
- 2.2.3 Antiparasitic Drugs Forecasted Market Size by Regions (2021-2026)
- 2.3 Industry Trends and Growth Strategy
- 2.3.1 Market Trends
- 2.3.2 Market Drivers
- 2.3.3 Market Challenges
- 2.3.4 Market Restraints
3 Competition Landscape by Key Players
- 3.1 Global Top Antiparasitic Drugs Players by Market Size
- 3.1.1 Global Top Antiparasitic Drugs Players by Revenue (2015-2020)
- 3.1.2 Global Antiparasitic Drugs Revenue Market Share by Players (2015-2020)
- 3.2 Global Antiparasitic Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Players Covered: Ranking by Antiparasitic Drugs Revenue
- 3.4 Global Antiparasitic Drugs Market Concentration Ratio
- 3.4.1 Global Antiparasitic Drugs Market Concentration Ratio (CR5 and HHI)
- 3.4.2 Global Top 10 and Top 5 Companies by Antiparasitic Drugs Revenue in 2019
- 3.5 Key Players Antiparasitic Drugs Area Served
- 3.6 Key Players Antiparasitic Drugs Product Solution and Service
- 3.7 Date of Enter into Antiparasitic Drugs Market
- 3.8 Mergers & Acquisitions, Expansion Plans
4 Antiparasitic Drugs Breakdown Data by Type (2015-2026)
- 4.1 Global Antiparasitic Drugs Historic Market Size by Type (2015-2020)
- 4.2 Global Antiparasitic Drugs Forecasted Market Size by Type (2021-2026)
5 Antiparasitic Drugs Breakdown Data by Application (2015-2026)
- 5.1 Global Antiparasitic Drugs Historic Market Size by Application (2015-2020)
- 5.2 Global Antiparasitic Drugs Forecasted Market Size by Application (2021-2026)
6 North America
- 6.1 North America Antiparasitic Drugs Market Size (2015-2026)
- 6.2 North America Antiparasitic Drugs Market Size by Type (2015-2020)
- 6.3 North America Antiparasitic Drugs Market Size by Application (2015-2020)
- 6.4 North America Antiparasitic Drugs Market Size by Country (2015-2020)
- 6.4.1 United States
- 6.4.2 Canada
7 Europe
- 7.1 Europe Antiparasitic Drugs Market Size (2015-2026)
- 7.2 Europe Antiparasitic Drugs Market Size by Type (2015-2020)
- 7.3 Europe Antiparasitic Drugs Market Size by Application (2015-2020)
- 7.4 Europe Antiparasitic Drugs Market Size by Country (2015-2020)
- 7.4.1 Germany
- 7.4.2 France
- 7.4.3 U.K.
- 7.4.4 Italy
- 7.4.5 Russia
- 7.4.6 Nordic
- 7.4.7 Rest of Europe
8 China
- 8.1 China Antiparasitic Drugs Market Size (2015-2026)
- 8.2 China Antiparasitic Drugs Market Size by Type (2015-2020)
- 8.3 China Antiparasitic Drugs Market Size by Application (2015-2020)
- 8.4 China Antiparasitic Drugs Market Size by Region (2015-2020)
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 South Korea
- 8.4.4 Southeast Asia
- 8.4.5 India
- 8.4.6 Australia
- 8.4.7 Rest of Asia-Pacific
9 Japan
- 9.1 Japan Antiparasitic Drugs Market Size (2015-2026)
- 9.2 Japan Antiparasitic Drugs Market Size by Type (2015-2020)
- 9.3 Japan Antiparasitic Drugs Market Size by Application (2015-2020)
- 9.4 Japan Antiparasitic Drugs Market Size by Country (2015-2020)
- 9.4.1 Mexico
- 9.4.2 Brazil
10 Southeast Asia
- 10.1 Southeast Asia Antiparasitic Drugs Market Size (2015-2026)
- 10.2 Southeast Asia Antiparasitic Drugs Market Size by Type (2015-2020)
- 10.3 Southeast Asia Antiparasitic Drugs Market Size by Application (2015-2020)
- 10.4 Southeast Asia Antiparasitic Drugs Market Size by Country (2015-2020)
- 10.4.1 Turkey
- 10.4.2 Saudi Arabia
- 10.4.3 UAE
- 10.4.4 Rest of Middle East & Africa
11Key Players Profiles
- 11.1 Ipca Laboratories Ltd
- 11.1.1 Ipca Laboratories Ltd Company Details
- 11.1.2 Ipca Laboratories Ltd Business Overview
- 11.1.3 Ipca Laboratories Ltd Antiparasitic Drugs Introduction
- 11.1.4 Ipca Laboratories Ltd Revenue in Antiparasitic Drugs Business (2015-2020))
- 11.1.5 Ipca Laboratories Ltd Recent Development
- 11.2 Zydus Cadila
- 11.2.1 Zydus Cadila Company Details
- 11.2.2 Zydus Cadila Business Overview
- 11.2.3 Zydus Cadila Antiparasitic Drugs Introduction
- 11.2.4 Zydus Cadila Revenue in Antiparasitic Drugs Business (2015-2020)
- 11.2.5 Zydus Cadila Recent Development
- 11.3 Merck
- 11.3.1 Merck Company Details
- 11.3.2 Merck Business Overview
- 11.3.3 Merck Antiparasitic Drugs Introduction
- 11.3.4 Merck Revenue in Antiparasitic Drugs Business (2015-2020)
- 11.3.5 Merck Recent Development
- 11.4 Pfizer
- 11.4.1 Pfizer Company Details
- 11.4.2 Pfizer Business Overview
- 11.4.3 Pfizer Antiparasitic Drugs Introduction
- 11.4.4 Pfizer Revenue in Antiparasitic Drugs Business (2015-2020)
- 11.4.5 Pfizer Recent Development
- 11.5 GlaxoSmithKline Plc.
- 11.5.1 GlaxoSmithKline Plc. Company Details
- 11.5.2 GlaxoSmithKline Plc. Business Overview
- 11.5.3 GlaxoSmithKline Plc. Antiparasitic Drugs Introduction
- 11.5.4 GlaxoSmithKline Plc. Revenue in Antiparasitic Drugs Business (2015-2020)
- 11.5.5 GlaxoSmithKline Plc. Recent Development
- 11.6 Cipla Ltd
- 11.6.1 Cipla Ltd Company Details
- 11.6.2 Cipla Ltd Business Overview
- 11.6.3 Cipla Ltd Antiparasitic Drugs Introduction
- 11.6.4 Cipla Ltd Revenue in Antiparasitic Drugs Business (2015-2020)
- 11.6.5 Cipla Ltd Recent Development
- 11.7 Ranbaxy Laboratories
- 11.7.1 Ranbaxy Laboratories Company Details
- 11.7.2 Ranbaxy Laboratories Business Overview
- 11.7.3 Ranbaxy Laboratories Antiparasitic Drugs Introduction
- 11.7.4 Ranbaxy Laboratories Revenue in Antiparasitic Drugs Business (2015-2020)
- 11.7.5 Ranbaxy Laboratories Recent Development
- 11.8 Novartis AG
- 11.8.1 Novartis AG Company Details
- 11.8.2 Novartis AG Business Overview
- 11.8.3 Novartis AG Antiparasitic Drugs Introduction
- 11.8.4 Novartis AG Revenue in Antiparasitic Drugs Business (2015-2020)
- 11.8.5 Novartis AG Recent Development
- 11.9 Alvizia Health Care
- 11.9.1 Alvizia Health Care Company Details
- 11.9.2 Alvizia Health Care Business Overview
- 11.9.3 Alvizia Health Care Antiparasitic Drugs Introduction
- 11.9.4 Alvizia Health Care Revenue in Antiparasitic Drugs Business (2015-2020)
- 11.9.5 Alvizia Health Care Recent Development
- 11.10 Bayer AG
- 11.10.1 Bayer AG Company Details
- 11.10.2 Bayer AG Business Overview
- 11.10.3 Bayer AG Antiparasitic Drugs Introduction
- 11.10.4 Bayer AG Revenue in Antiparasitic Drugs Business (2015-2020)
- 11.10.5 Bayer AG Recent Development
- 11.11 Roche Inc
- 10.11.1 Roche Inc Company Details
- 10.11.2 Roche Inc Business Overview
- 10.11.3 Roche Inc Antiparasitic Drugs Introduction
- 10.11.4 Roche Inc Revenue in Antiparasitic Drugs Business (2015-2020)
- 10.11.5 Roche Inc Recent Development
- 11.12 Arbor Pharmaceuticals Inc.
- 10.12.1 Arbor Pharmaceuticals Inc. Company Details
- 10.12.2 Arbor Pharmaceuticals Inc. Business Overview
- 10.12.3 Arbor Pharmaceuticals Inc. Antiparasitic Drugs Introduction
- 10.12.4 Arbor Pharmaceuticals Inc. Revenue in Antiparasitic Drugs Business (2015-2020)
- 10.12.5 Arbor Pharmaceuticals Inc. Recent Development
- 11.13 Sanofi
- 10.13.1 Sanofi Company Details
- 10.13.2 Sanofi Business Overview
- 10.13.3 Sanofi Antiparasitic Drugs Introduction
- 10.13.4 Sanofi Revenue in Antiparasitic Drugs Business (2015-2020)
- 10.13.5 Sanofi Recent Development
- 11.14 AstraZeneca
- 10.14.1 AstraZeneca Company Details
- 10.14.2 AstraZeneca Business Overview
- 10.14.3 AstraZeneca Antiparasitic Drugs Introduction
- 10.14.4 AstraZeneca Revenue in Antiparasitic Drugs Business (2015-2020)
- 10.14.5 AstraZeneca Recent Development
- 11.15 Alkem Laboratories Limited
- 10.15.1 Alkem Laboratories Limited Company Details
- 10.15.2 Alkem Laboratories Limited Business Overview
- 10.15.3 Alkem Laboratories Limited Antiparasitic Drugs Introduction
- 10.15.4 Alkem Laboratories Limited Revenue in Antiparasitic Drugs Business (2015-2020)
- 10.15.5 Alkem Laboratories Limited Recent Development
12Analyst's Viewpoints/Conclusions
13Appendix
- 13.1 Research Methodology
- 13.1.1 Methodology/Research Approach
- 13.1.2 Data Source
- 13.2 Disclaimer
Summary:
Get latest Market Research Reports on and China Antiparasitic Drugs. Industry analysis & Market Report on and China Antiparasitic Drugs is a syndicated market report, published as Global and China Antiparasitic Drugs Market Size, Status and Forecast 2020-2026. It is complete Research Study and Industry Analysis of and China Antiparasitic Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
